KROS Next Earnings Date Notes

— Keros Therapeutics (KROS) is a clinical-stage biopharmaceutical company focused on developing innovative treatments for diseases linked to dysfunction in the transforming growth factor-beta (TGF-β) superfamily pathways, including severe hematological and musculoskeletal disorders. Its lead asset, KER-050, is in clinical trials for treating anemia in patients with myelodysplastic syndromes (MDS) and myelofibrosis, while other pipeline candidates target related pathways in rare diseases. For investors tracking KROS's long-term potential, key metrics to watch in each quarterly earnings call include clinical development timelines (particularly readouts and trial initiations of KER-050, KER-012, & KER-047), updates on enrollment progress, and any preliminary efficacy & safety data. Cash runway and R&D spending are also essential since Keros is pre-revenue and must demonstrate prudent capital management alongside pipeline advancement. Finally, listen for management commentary on partnership opportunities and regulatory feedback, which can signal external validation and facilitate commercialization. Focusing on these metrics will help gauge both the near-term momentum and long-term sustainability of Keros’s business model. The next projected earnings date for KROS is 5/5/2026 after close (stay tuned for a confirmed earnings date once announced).

KROS Next Earnings Date FAQ

On this page we presented the KROS Next Earnings Date information for Keros Therapeutics along with recent past earnings dates. For Q4 of 2025, KROS reported earnings of -0.860/share, with the earnings report taking place on 3/4/2026. For Q3 of 2025, KROS reported earnings of -0.180/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, KROS reported earnings of -0.760/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, KROS reported earnings of 3.620/share, with the earnings report taking place on 5/6/2025. For Q4 of 2024, KROS reported earnings of -1.140/share, with the earnings report taking place on 2/26/2025. Based on these past earnings dates, the projected next earnings date for KROS is 5/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Keros Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Keros Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Keros Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next KROS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up KROS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the KROS next earnings date.